Introduction
Fifty years ago, Hodgkin disease (HD, also known as Hodgkin’s disease), a cancer of the lymphatic system*, was nearly uniformly fatal. With the introduction of effective treatment regimens, HD is now a potentially curable cancer, associated with an 85 percent five-year relative survival rate. There are currently about 120,000 survivors of HD in the United […]

The National Cancer Institute (NCI) today announced the funding of a new initiative to pool data and biospecimens from 10 large study populations to conduct research on gene-environment interactions in cancer etiology. The investigative teams will collaborate on studies of hormone-related gene variants and environmental factors involved in the development of breast and prostate cancer. […]

New data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial give fresh insight into the appropriate screening intervals for colorectal cancer after a negative exam. The interim report published in the July 2 issue of the Journal of the American Medical Association* is the largest study to date of repeat sigmoidoscopy screening […]

The National Cancer Institute (NCI) today announced the appointment of Robert T. Croyle, Ph.D., as director of its Division of Cancer Control and Population Sciences (DCCPS). Croyle has been the acting division director since November 2002, and is the division’s former associate director for behavioral research.